Please provide your email address to receive an email when new articles are posted on . In 2023, nearly a third of hospitalized patients with chronic liver disease had acute kidney injury or ...
Metabolic dysfunction, rather than steatotic liver disease (SLD), seems to be the main driver of chronic kidney disease (CKD) risk.
News-Medical.Net on MSN
How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?
By Hugo Francisco de Souza A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results